THE IMPACT OF INR SELF-MONITORING (PATIENT SELF-TESTING AND SELF-MANAGEMENT) ON THE INCIDENCE OF THROMBOTIC AND HEMORRHAGIC COMPLICATIONS IN PATIENTS TREATED WITH VITAMIN K ANTAGONISTS: A LITERATURE REVIEW
Open Access
- 2 March 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
Abstract
Vitamin K antagonists (VKAs) remain essential in the management of patients with mechanical heart valves, rheumatic mitral stenosis, and selected cases of atrial fibrillation. Because therapeutic effectiveness depends on maintaining the international normalized ratio (INR) within a narrow target range, strategies that improve INR stability are critical to reducing the risks of thromboembolic and hemorrhagic complications. Traditional clinic-based monitoring is limited by infrequent testing and delayed dose adjustments, prompting growing interest in patient self-testing (PST) and patient self-management (PSM). This review assessed the impact of PST and PSM on anticoagulation quality and clinical outcomes in adults treated with VKAs. A targeted PubMed search (2015–2025) identified meta-analyses and randomized controlled trial evaluating INR self-monitoring. Three high-quality sources—a Cochrane review, a network meta-analysis, and a meta-analysis focused on telemedicine-supported PST—served as the primary evidence base. Across studies, both PST and PSM significantly increased time in therapeutic range (TTR), typically by 5–10 percentage points compared with standard care. PSM and telemedicine-assisted PST demonstrated the greatest improvements. Enhanced TTR translated into reductions in thromboembolic events, particularly in high-intensity PSM strategies. Importantly, no increase in major bleeding was observed in any self-monitoring model, indicating a favorable safety profile. In conclusion, INR self-monitoring, especially intensive PSM and telemedicine-enabled PST, offers an effective and safe approach to improving anticoagulation control in patients requiring long-term VKA therapy. These strategies address well-recognized limitations of traditional INR monitoring and support more responsive, patient-centered care.Keywords
This publication has 24 references indexed in Scilit:
- Appropriate target range of INR and predictive factors of recurrent thrombosis and bleeding in patients with venous thromboembolism on warfarinScientific Reports, 2025
- Study of target INR achievement, incidence of hemorrhagic complications and affecting factors after during warfarin treatment in western area of ChinaScientific Reports, 2025
- Comparison of the Latest ESC, ACC/AHA/ACCP/HRS, and CCS Guidelines on the Management of Atrial FibrillationJACC: Clinical Electrophysiology, 2025
- There is still no alternative to warfarin for mechanical valves: It remains the most effective anticoagulantThe Journal of Thoracic and Cardiovascular Surgery, 2024
- Comparative effectiveness of warfarin management strategies: a systematic review and network meta-analysiseClinicalMedicine, 2024
- Is There an Alternative Oral Anticoagulation to Vitamin-K-Antagonists for Patients with Mechanical Aortic Valve Replacement? – A Literature ReviewCardiology and Therapy, 2024
- Outcomes of Warfarin Home INR Monitoring vs Office-Based Monitoring: a Retrospective Claims-Based AnalysisJournal of General Internal Medicine, 2023
- Clinical Outcomes of Different Warfarin Self-Care Strategies: A Systematic Review and Network Meta-AnalysisThrombosis and Haemostasis, 2021
- Anticoagulation control with the point-of-care INR: A retrospective pre-/post-analysisThrombosis Research, 2020
- Self-monitoring and self-management of oral anticoagulationCochrane Database of Systematic Reviews, 2016